Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cinnamaldehyde, the main compound in cinnamon essential oil, has been traditionally used in various cultures to manage symptoms of colds and respiratory infections. However, its use for colds as an antiviral is primarily grounded in preliminary scientific studies rather than strong clinical evidence. In vitro research has demonstrated that cinnamaldehyde exhibits antiviral properties against certain viruses, including some strains of influenza and respiratory syncytial virus (RSV). These effects are thought to arise from its ability to disrupt viral envelopes and inhibit viral replication. Additionally, cinnamaldehyde has shown anti-inflammatory and antioxidant activities, which may provide some symptomatic relief during respiratory infections.

Despite these promising laboratory findings, there is a lack of robust human clinical trials evaluating cinnamaldehyde’s efficacy specifically for treating or preventing the common cold. Most existing studies have been conducted in cell cultures or animal models, and their direct applicability to human health remains uncertain. While cinnamaldehyde is generally recognized as safe in food amounts, its medicinal use for colds has not been formally established. Thus, although there is some scientific rationale and early experimental support, the current evidence base is limited and does not justify its routine use for colds as an antiviral agent.

More about Cinnamaldehyde
More about Colds (antiviral)

Other ingredients used for Colds (antiviral)

Other health conditions supported by Cinnamaldehyde

Products containing Cinnamaldehyde